Tagungen und Workshops zum Thema Onkologie

Wählen Sie ein Land aus:
Australien (2) - Belgien (1) - Deutschland (13) - Frankreich (1) - Großbritannien (13) - Indien (3) - Japan (1) - Mexiko (3) - Neuseeland (1) - Niederlande (2) - Portugal (1) - Schweiz (2) - Singapur (2) - Südafrika (1) - Vereinigte Arabische Emirate (2) - Vereinigte Staaten (31) - Österreich (1)

ALLE LÄNDER

1
Cancer Genetics Course 2018
29. Jan 2017 - 01. Feb 2018 • London, Großbritannien
Zusammenfassung:
The field of cancer genomics and recent technological advances are shaping how we diagnose and treat cancer. This skills based course will teach the core concepts of risk stratification using family history as a tool to enable patients to access appropriate management strategies. It is a course designed for all healthcare professionals working in primary care and specialist settings including oncology, breast care, gynae-oncology, gastroenterology and screening services. Participants will be equipped with the basics of cancer genetic counselling and sessions will include approaches to genetic testing, management of hereditary cancers and consent taking.
Kontakt:
Charlotte Davis;     Tel.: [+44 (0)20 7188 7188];     Email: events@gstt.nhs.uk
Themen:
genetics, oncology, breast-care, gynae-oncology, gastroenterology
Eintrags-ID:
934050
Verwandte Fachgebiete:
2
Joint meeting of the 9th World Congress of Melanoma and 14th International Congress of the Society for Melanoma Research
18. Okt 2017 - 21. Okt 2017 • Brisbane, Australien
Kontakt:
Vivien Lietze;     Tel.: [+4930204590];     Email: congress@worldmelanoma2017.com
Themen:
Dermatology, Dermato-Oncology, Skin-Cancer, Melanoma
Eintrags-ID:
764380
Verwandte Fachgebiete:
3
29th Annual Fall Foliage Cancer Conference
20. Okt 2017 - 21. Okt 2017 • Asheville, Vereinigte Staaten
Zusammenfassung:
Overall Topics:
Kontakt:
Community Cancer Education, Inc., 900 Hendersonville Rd, Suite 311;     Tel.: [8282779706];     Email: sha@shallc.net
Themen:
oncology, cancer, breast, prostate, urology, gyn oncology, conference, fall, foliage, radiation, medical oncology, surgical oncology
Eintrags-ID:
909429
Verwandte Fachgebiete:
4
Immunotherapy A Special CE Program for Advanced Practitioners
21. Okt 2017 • Pittsburgh, Vereinigte Staaten
Zusammenfassung:
Become an integral part of the patient care team by learning about side effect management, recognition, and timing for immunotherapy related adverse effects. Interact with experts on best practices for your patients with diseases such as melanoma or non-small cell lung cancer through case-based discussions.
Kontakt:
Annamarie Luccarelli;     Tel.: [6098323000];     Email: annamarie@harborsidepress.com
Eintrags-ID:
934069
5
ICOR 2017 — International Conference on Oncology and Radiology
23. Okt 2017 - 25. Okt 2017 • Las Vegas, Vereinigte Staaten
Zusammenfassung:
The (ICOR 2017) Conference on Oncology and Radiology is an International Cancer Conference, a professional association that focuses on research in the field of Oncology. The aim of this association by constitution is to promote research in all fields of Cancer and related sciences, to encourage improvements in methods for the prevention and treatment of Cancer, to improve the health of the public through research, and to facilitate cooperation among investigators and the communication of research findings and their implications throughout the world. Plus, you'll have the opportunity to connect with more than 500 of your peers and celebrate your profession. You'll leave better educated and more invigorated than you thought possible. We wish to see you in Las Vegas, a promising place to discover novel things in the field of science and technology.
Kontakt:
Michal Albert;     Tel.: [+1 (702) 988 2320];     Email: cancer@magnusconferences.com
Themen:
cancer conference, cancer conferences, cancer conferences 2017, oncology conference, oncology conferences, oncology conferences 2017, radiology conferences, global summit on oncology and radiology, oncology and radiology conferences 2017
Eintrags-ID:
874943
Verwandte Fachgebiete:
Webseite:
6
CoBrCa — 3rd World Congress on Controversies in Breast Cancer (CoBrCa)
26. Okt 2017 - 28. Okt 2017 • Tokyo, Japan
Zusammenfassung:
The 3rd CoBrCa Congress will continue the tradition of directly addressing controversial issues in breast cancer faced by clinicians in their daily practice. The 3rd CoBrCa will focus on key issues in medical oncology, surgery, radiation oncology, reconstruction and pathology. The congress will provide a forum to effectively debate these unresolved clinical and therapeutic problems.
Kontakt:
Secretariat;     Email: cobrca@congressmed.com
Themen:
Breast cancer, oncology, Breast imaging, Breast reconstruction,
Eintrags-ID:
876583
Verwandte Fachgebiete:
Webseite:
7
CRT-2017 — II International conference on CANCER RESEARCH AND TARGETED THERAPY
26. Okt 2017 - 28. Okt 2017 • MIAMI, FLORIDA, Vereinigte Staaten
Zusammenfassung:
United Scientific Group (USG) successfully completed I International Conference on Cancer Research and Targeted Therapy at Baltimore USA on Oct 21-23, 2016. With a great spirit and encouragement USG is proud to announce our II International Conference on Cancer Research and Targeted Therapy on Oct 26-28, 2017 at Miami Beach Resort, Miami, Florida, USA.
Kontakt:
Kinnera;     Tel.: [408-426-4832];     Email: cancer.therapy@uniscigroup.org
Themen:
The Cancer Cell, Cancer Metabolism, Cancer Metastasis, Cancer Stem Cell Biology, Cell Signal Transduction in development and Cancer, Molecular Oncology, Cancer Immunology, Checkpoint Inhibitors in Treating Cancers, Monoclonal Antibodies to Treat Cancer, Cancer Vaccines, Antitumor Immunity, Cancer Microenvironment, Tumor Biomarkers, Tumor Angiogenesis, Tumor Imaging, Cancer Models, Cancer Genomics, Organ Specific Cancer, Gynecological Cancer, Pediatric Cancer, Breast Cancer, Lung Cancer, Gastric Cancer, Oral Cancer
Eintrags-ID:
908560
8
Protecting the Code: Epigenetic Impacts on Genome Stability
29. Okt 2017 - 01. Nov 2017 • Berlin, Deutschland
Zusammenfassung:
The maintenance of genome stability takes place in a chromatin environment, and it is increasingly evident that epigenetic regulation is a key component of genome stability. Notably, epigenetic pathways are frequently perturbed in cancer cells. Understanding the interplay between epigenetic regulation and genome stability at a molecular level is critical to cancer biology and has important translational implications. The programme will address the challenges of understanding this complex field and will emphasise new experimental systems for interrogating these pathways. While the emphasis is on understanding molecular mechanisms of epigenetic impacts on genome stability, we will also consider how recent advances can be exploited in the clinic.
Kontakt:
Roger Doxat-Pratt;     Email: roger.doxat-pratt@nottingham.ac.uk
Themen:
epigenetics, epigenetic, impacts, genome, genomes, stability, DNA, damage, signalling, chromatin, remodelling, histone, modifications, repair, replication, environment, regulation, non-coding, RNAs, Berlin, Harnack
Eintrags-ID:
898693
9
The 5th Christie Metastatic Spinal Cord Compression Study Day
01. Nov 2017 • Manchester, Großbritannien
Zusammenfassung:
The 5th Christie Metastatic Spinal Cord Compression Study Day is an opportunity for attendees to better understand how to manage patients with suspected or confirmed metastatic spinal cord compression throughout the pathway. The day will share good practice and discuss the development of the Manchester Cancer MSCC Coordinator service .
Eintrags-ID:
911871
10
ABC4 — Advanced Breast Cancer Fourth ESO-ESMO International Consensus Conference
02. Nov 2017 - 04. Nov 2017 • Lissabon, Portugal
Zusammenfassung:
ABC has established itself as a major international breast cancer conference. Its primary aim is the development of international consensus guidelines for the management of advanced breast cancer patients. These treatment guidelines are based on the most up-to-date evidence and can be used and adapted to many different health care settings globally.
Kontakt:
Gabriele Maggini;     Tel.: [+41918200950];     Email: communication@eso.net
Themen:
Breast Cancer, Metastatic breast cancer, Advanced breast cancer, Metronomic chemotherapy
Eintrags-ID:
893976
11
JADPRO LIVE at APSHO 2017
02. Nov 2017 - 05. Nov 2017 • Houston, Vereinigte Staaten
Zusammenfassung:
The fifth annual JADPRO Live conference will be held in conjunction with the annual meeting of the Advanced Practitioner Society for Hematology and Oncology (APSHO) on November 2-5, 2017, at the Marriott Marquis, Houston, TX. APSHO's mission is to improve the quality of care for patients with cancer by supporting critical issues in educational, clinical, and professional development for advanced practitioners in hematology and oncology. JADPRO LIVE at APSHO provides CE-accredited educational sessions presented throughout the conference which will include didactic, interactive, evidence-based and fair-balanced content targeted to the advanced practitioners (APs) in oncology. The audience for this live conference consists of nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, hematology/oncology nurses, pharmacists, and physicians.
Kontakt:
Ceil Boyce;     Tel.: [609-853-0025];     Email: cboyce@harborsidepress.com
Themen:
Oncology, Hematology, nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, hematology/oncology nurses, pharmacists, physicians.
Eintrags-ID:
910352
12
ESGO 2017 Congress in Vienna — 20th Biennial International Meeting of the European Society of Gynaecological Oncology
04. Nov 2017 - 07. Nov 2017 • Wien, Österreich
Zusammenfassung:
Held biennially, ESGO congress offers professionals in Gynaecological Oncology - including clinicians, researchers, residents and students a unique opportunity to learn and discuss the latest medical and scientific developments in gynaecological cancers research, treatment and care, as well as to network with key opinion leaders and peers from around the world.
Kontakt:
Lucie Lamlova;     Email: lucie.lamlova@esgomail.org
Themen:
the latest medical and scientific development, gynaecological cancers research, treatment and care
Eintrags-ID:
825922
Verwandte Fachgebiete:
13
EMBL Conference: Cancer Genomics
05. Nov 2017 - 08. Nov 2017 • Heidelberg, Deutschland
Zusammenfassung:
This conference will provide an opportunity to learn about and keep up to date with the rapidly progressing area of cancer genomics. It will cover presentations from cancer genome projects, the areas of cancer functional genomics, systems biology, cancer mouse models and the translation and clinical impact of scientific results obtained. The meeting will bring together leading scientists from across these areas for a unique opportunity to interact and stimulate further integration of these efforts.

European Cancer Genomics research is particularly strong in the Heidelberg area, with three International Cancer Genome Consortium (www.icgc.org) projects being currently pursued with significant participation from Heidelberg institutions, including EMBL. As in our 2015 meeting, a large number of renowned speakers will be invited, with a strong representation of overseas speakers. The atmosphere at the conference will make this an exceptional event with cutting edge science, extensive scientific discussions and ample possibilities for meetings between and after sessions to facilitate in-depth discussions and new collaborations.

Kontakt:
Tel.: [4962213878797];     Email: marketing@embl.de
Eintrags-ID:
834523
Verwandte Fachgebiete:
14
NCRI — 2017 NCRI Cancer Conference
05. Nov 2017 - 08. Nov 2017 • Liverpool, Großbritannien
Zusammenfassung:
The NCRI Cancer Conference is the largest annual cancer research meeting in the UK, attracting over 1,500 participants from across the spectrum of basic, translational and clinical research. We are committed to share and make available to all attendees the best cancer research from all over the world and encourage cross-pollination. The Conference provides a high profile platform where key stakeholders of cancer research come together to discuss, present and showcase high-quality research. The programme covers six main themes - Diagnosis and therapy, Epidemiology and prevention, Health services research, Information, patients and the public, Survivorship and end of life care and the cancer cell and model systems – which are organised in sessions across 4 days. The Conference programme includes plenty of networking opportunities, allowing participants to make the most of their time in Liverpool.
Kontakt:
NCRI Conference and Events Team;     Tel.: [+44 (0)20 3469 5453];     Email: ncriconference@ncri.org.uk
Themen:
Cancer, basic science, translational research, clinical trials, clinical research, collaboration, share, knowledge, latest advances in cancer research, cancer research, diagnosis, therapy, epidemiology, prevention, health, health services, patients, consumers, patient experts, survivorship, end of life care, palliative care, living with and beyond cancer, cancer cell, cancer model systems, networking, abstract submission
Eintrags-ID:
882465
15
Frontiers in Cancer Science 2017
06. Nov 2017 - 08. Nov 2017 • Singapore, Singapur
Zusammenfassung:
Serving as a platform to converge the latest cancer discoveries around the world, the meeting promises to bring groundbreaking and innovative insights to a diverse repertoire of cancer research. Learn from 30 of the foremost cancer experts as they share their newest findings and gain invaluable networking opportunities locally and internationally.
Eintrags-ID:
923776
16
Disrupting Cancer: The Role of Personalized Nutrition
08. Nov 2017 - 10. Nov 2017 • Alexandria, Vereinigte Staaten
Zusammenfassung:
The science is clear: nutrition is the single most important determinant of health and a strong influencer of cancer expression. Emerging research indicates that cancer is not simply a binary hereditary disease, but a complex chronic condition occurring along a spectrum of immune and metabolic function with many factors impacting risk, onset and severity. The personalized nutrition paradigm is poised to disrupt both the narrative of cancer and the methodologies we employ in its treatment and prevention. Learn from innovative thought leaders, researchers and clinicians at the nexus of cancer and nutrition. Discover how nutrition intersects with current research in systems biology, epigenetics, nutrigenomics, metabolomics, and the microbiome to impact the trajectory of cancer. 
Eintrags-ID:
923761
17
ICC2017 — 2nd Indian Cancer Congress
08. Nov 2017 - 12. Nov 2017 • BANGALORE, Indien
Zusammenfassung:
The Indian Cancer congress is an amalgamation of the four major national oncology associations ( The Association of Radiation Oncologists of India, Indian Association of Surgical Oncology, the Indian Society of Medical & Pediatric Oncologists and the Indian Society of Oncology) . This conference is a planned quadrennial event of these four associations and all other sub specialty associations to improve the quality of cancer care through multidisciplinary interactionand will be held in various parts of the Indian subcontinent once every four years. The ICC2017 conference is scheduled to be held from 9th to 12th November 2017 (with pre-conference workshop held on 8th Nov 2017) in Bengaluru, India.The theme for the conference is “INSIGHT, INNOVATION, INTEGRATION” The field of oncology is rapidly evolving and is in constant flux. What is thought to be true today may very soon be turned on its head by new insights and new innovations. It is therefore prudent and necessary that we the oncology community – periodically stop in our fast tracks and take stock of some important insights and innovations and debate how best we can integrate these innovations into our practice. The congress hopes to attract each and everyone involved in the care of the cancer patient including physicians, basic scientists, patients, survivors , care givers, researchers, investors etc and to provide a platform from which meaningful value addition can emerge.
Kontakt:
Nalini Rao;     Tel.: [9845517681];     Email: nkrao@hotmail.com
Eintrags-ID:
833928
18
Multidisciplinary Update in Breast Disease
09. Nov 2017 - 11. Nov 2017 • Atlantic Beach, Vereinigte Staaten
Zusammenfassung:
This two and half day continuing medical education course will provide a multidisciplinary update from experts in their field focusing on prevention, evaluation, diagnosis, management, and treatment of benign and malignant breast diseases, high risk and survivorship issues.
Eintrags-ID:
923824
Verwandte Fachgebiete:
19
SYNERGY 2017
09. Nov 2017 - 12. Nov 2017 • Miami Beach, FL, Vereinigte Staaten
Zusammenfassung:
The annual SYNERGY conference offers attendees a comprehensive review of a variety of oncological diseases, combined with the latest developments in medical, interventional and surgical therapeutic options across multiple disciplines. A practical overview of how to incorporate emerging therapies into practice will be presented through a multidisciplinary lens, intended to achieve the highest levels of success in the fight against cancer. Leading experts from around the globe will present the latest data and treatment innovations for oncological challenges in multiple organ systems with an emphasis on implementation from diagnosis to treatment. SYNERGY is both didactic and interactive with panel discussions, instructive case presentations and hands-on workshops.
Kontakt:
Tel.: [305-279-2263];     Email: questions@ccmcme.com
Themen:
interventional radiology, hepatocellular carcinoma, lung cancer, metastatic colorectal cancer, cholangiocarcinoma, liver metastases, renal cancer, prostate cancer, pancreatic cancer, neuroendocrine, musculoskeletal tumors
Eintrags-ID:
927218
20
Fortbildungsveranstaltung "Leitlinien-Update Onkologie": S3-Leitlinie Palliativmedizin
10. Nov 2017 • Berlin, Deutschland
Kontakt:
Juliane Truskowski;     Tel.: [03643 2468-129];     Email: juliane.truskowski@ng-akademie.de
Eintrags-ID:
939255
21
Thyroid Cancer 2017: New Advances in Diagnosis and Treatment
10. Nov 2017 • Philadelphia, Vereinigte Staaten
Zusammenfassung:
Thyroid Cancer 2017: New Advances in Diagnosis and Treatment will evaluate and present the recent advances in diagnostic and therapeutic approaches to Thyroid Cancer and Thyroid Nodular Disease that have altered traditional management paradigms. The latest evidence-based guidelines from the American Thyroid Association and the new 2018 staging system from the American Joint Commission on Cancer will be reviewed and practitioners will be provided with an array of contemporary management elements with which to approach patients with Thyroid Nodular Disease and Cancer. This course is designed for all otolaryngologist, endocrinologist, endocrine & general surgeon, oncologist, primary care practitioner, and other health care professionals.
Kontakt:
Jefferson CME;     Tel.: [215-955-6992];     Email: JEFFERSONCPD@JEFFERSON.EDU
Themen:
otolaryngologist, endocrinologist, endocrine, general surgeon, oncologist, primary care practitioner, health care professionals, thyroid, cancer, treatment, diagnosis, advances, evidence, 2017, 2018, jefferson, cme
Eintrags-ID:
928551
Verwandte Fachgebiete:
22
Mayo Clinic Cancer Center Thoracic Oncology Update: State-of-the-Art Evaluation and Management of Thoracic Cancers
10. Nov 2017 - 11. Nov 2017 • Phoenix, Vereinigte Staaten
Zusammenfassung:
Thoracic malignancies represent the leading cause of cancer death in the United States. This continuing medical education activity will focus on recent developments in medical, surgical, radiation and medical oncologic care of patients with malignancies of the chest. The conference will emphasize recent developments in molecular pathways of carcinogenesis and immunobiology as well as novel surgical and interventional techniques. Important clinical advances and clinical trials including surgical, medical, radiation and palliative management will be presented by a distinguished faculty.
Eintrags-ID:
923855
Verwandte Fachgebiete:
23
NZBCS-2017 — The New Zealand Breast Cancer Symposium - United for a Cure Through Research
12. Nov 2017 - 14. Nov 2017 • Auckland, Neuseeland
Zusammenfassung:
We are so pleased that Professor Sir David Lane, Professor Geoffrey Lindeman, Professor Peter Lobie, and Assistant Professor Andrew Green are going to deliver keynote speeches during the conference. In addition, many other clinicians and research scientists have already confirmed their attendance (see the website: www.nzbcs.org.nz). We expect there will be around 250 local and 500 international guests will attend the meeting. The oral presentations and posters will cover all aspects of clinical, translational, and basic research on breast cancer. The meeting will provide a unique and ideal forum for a broad spectrum of researchers, clinicians, health professionals and those with a special interest in breast cancer to discuss research and share ideas for finding a cure for breast cancer.
Kontakt:
A/Prof Dong-Xu Liu;     Tel.: [+64 9 921 9999];     Email: nzbcs@aut.ac.nz
Themen:
Breast Cancer, New Zealand, NZBCS, Auckland, Symposium, Biomarker, Targeted Therapy, Immunotherapy
Eintrags-ID:
908943
24
GMB17 — Genomic Medicine 2017 Benelux Conference
15. Nov 2017 - 16. Nov 2017 • Brüssel, Belgien
Zusammenfassung:
Genomic Medicine 2017 Benelux is the second annual genomics event and the conference will look at the latest developments in the use of Genomics tools & technologies focusing on Next Generation Sequencing (NGS) to understand human disease. It will take place on 15th & 16th November at the Musée de la Médecine (Museum of Medicine), Campus Erasme, Brussels.
Kontakt:
Elisabetta Fineschi;     Email: genmedbenelux@biotexcel.com
Themen:
Genomics, Genetics, NGS, Next Generation Sequencing, Bioinformatics, Clinical Genetics, Oncology, Cancer, Clinical Genomics, Molecular Biology, Data Analysis, Human Genetics, Biomarkers, Data Storage, Rare Disease, Micro RNA, Circulating Tumour DNA, Cfdna, Mirna, Epigenetics, Transcriptomics, Oncogenomics, Microbiome, Metagenomics, NGS Data Analysis, Personalized Medicine, Diagnostics, Infectious And Inherited Diseases, Molecular Diagnostics
Eintrags-ID:
914959
Verwandte Fachgebiete:
25
Cancer Meeting 2017 — World Cancer Meeting
16. Nov 2017 - 17. Nov 2017 • Singapore, Singapur
Zusammenfassung:
Meet Global oncologists and Cancer specialists from USA, Europe, Middle East and Asia-Pacific to “World Cancer Meeting” held at Singapore during November 16-17, 2017. The meeting aims to bring together international & regional faculty experts in Cancer.
Kontakt:
Rachel Geller;     Tel.: [800-101-2526];     Email: cancer@oncologymeeting.org
Themen:
• Cancer • Cancer Biology • Cancer Genetics • Precision Medicine and Cancer Therapy • Cancer Diagnosis and Cancer Diagnostics • Stem Cell Therapy • Cancer Case Reports • Novel Approaches to Cancer Therapeutics • Cancer Screening • Resistance and Tumor Evolution • Oncogenomics • Oncology and Hematology • Cancer Epidemiology • Obesity and Cancer • Cancer Management and Prevention
Eintrags-ID:
910900
26
EOC 2017 — 6th annual Emirates Oncology Conference
16. Nov 2017 - 18. Nov 2017 • Abu Dhabi, Vereinigte Arabische Emirate
Zusammenfassung:
6th annual Emirates Oncology Conference program with a theme “Personalizing Cancer Treatment – A Multidisciplinary Approach” has been designed to cover a breadth of topics in oncology, including almost all the key sub-specialties of oncology. Presentations prepared by global experts as well as panel discussions will provide our delegates with the very latest information on best practices and the most recent developments in cancer research, diagnosis and treatment.
Kontakt:
Rhodora Francisco;     Tel.: [+97137677444 ext. 2153];     Email: info@eoc2017.ae
Themen:
 Breast / Gynecological Malignancies  Lung Cancer  Adult Hematology- Oncology – Lymphoma  Adult Hemato-Oncology – Leukemia  Palliative Care  Paediatric Oncology  Gastro-Intestinal Malignancies  Breast Cancer  Head and Neck Cancer  Adult Survivorship
Eintrags-ID:
943556
Webseite:
27
14. AIO-Herbstkongress
16. Nov 2017 - 18. Nov 2017 • Berlin, Deutschland
Zusammenfassung:
Vom 16. bis 18. November 2017 findet der 14. AIO-Herbstkongress „Update Medical Oncology“ im Hotel Pullman Berlin Schweizerhof statt. Wie schon in den vergangenen Jahren steht der Kongress ganz im Zeichen der klinischen Forschungsarbeit des Themenbereiches der soliden Tumoren und der Translationalen Forschung. Der AIO-Herbstkongress wird inhaltlich von den Arbeits- und Studiengruppen der AIO gestaltet und befasst sich schwerpunktmäßig mit dem wissenschaftlichen Update dieser Studienaktivitäten. Das Format des AIO-Herbstkongresses mit seinen Plenar- und Gruppensitzungen, Symposien und Diskussionsrunden hat sich bewährt, was nicht zuletzt an den steigenden Teilnehmerzahlen und einer umfangreichen begleitenden Industrieausstellung ersichtlich ist.
Kontakt:
Andreas Kandler;     Tel.: [+49 (0)89 549096-77];     Email: aio-herbstkongress@mci-group.com
Themen:
Mammakarzinom und Gynäkologische Tumoren, Ösophagus-/Magenkarzinom, Kolon-/Rektum-/Dünndarmtumoren, Weichteilsarkome/Knochentumoren, Thorakale Onkologie, Urogenitaltumoren
Eintrags-ID:
873065
28
NGA-WinterGespräche 2017: Der onkologische Patient im Mittelpunkt
17. Nov 2017 - 18. Nov 2017 • Tübingen, Deutschland
Zusammenfassung:
Um Ihr Fachwissen in der onkologischen Pflege zu vertiefen und die Herausforderung zu meistern, Betroffene mit einer Krebserkrankungen aktiv bei ihren Entscheidungsprozessen zu unterstützen, bieten wir Ihnen jährlich Interessantes und Neues aus der Medizin und Pflege bei Karzinomerkrankungen an.
Kontakt:
Juliane Truskowski;     Tel.: [03643 2468-129];     Email: juliane.truskowski@ng-akademie.de
Themen:
Onkologie, Pflege
Eintrags-ID:
936347
29
ACCI 2017 - Affordable Cancer Care India 2017 - Cancer Care Event
18. Nov 2017 • Neu-Delhi, Indien
Zusammenfassung:
BCPBF – The Cancer Foundation, is committed to making personalized cancer care affordable across this country. ACCI 2017, in collaboration with policymakers and experts, is one of our strongest steps forward.
Kontakt:
Dr. Mridul Arora;     Tel.: [9811061709];     Email: info@bcpbf.com
Themen:
#Cancercare, #acci_2017, #CancerPolicy #CancerFoundation, #oncologist, #cancertreatment, #cancerawareness
Eintrags-ID:
954517
Verwandte Fachgebiete:
30
WAR ON CANCER LONDON
21. Nov 2017 • London, Großbritannien
Zusammenfassung:
The Economist Events' third annual War on Cancer summit will take place on November 21st 2017 in London. The event will bring together editors from The Economist together with stakeholders in oncology - including policy makers, pharmaceutical companies, cancer organisations and healthcare providers. The 2017 edition will focus on the topic of 'a patient's journey' with panel sessions including: caring for cancer patients, digital health and cancer care, precision medicine, and patients and policy.
Kontakt:
Georgia Grant;     Tel.: [+44 (0) 207 576 8118];     Email: emeaevents@economist.com
Eintrags-ID:
934228
31
Oncology Clinical Experience
21. Nov 2017 - 23. Nov 2017 • Leeds, Großbritannien
Zusammenfassung:
What is Oncology Clinical Experience? Oncology Clinical Experience is a hospital based oncology training course and combines theoretical teaching with practical example. Physician taught lectures are combined with visits to clinics and delegates have the opportunity to interact with patients in small group sessions. Oncology Clinical Experience offers rapid and progressive face-to-face training taught by clinician experts and the care team.  This course thoroughly equips attendees with theoretical and practical knowledge to discuss Oncology and its treatment confidently and credibly. Participants are provided with an overview of the spectrum of malignant disease and there is unique opportunity for delegates to experience – first hand – the assessment and treatment options utilised within the overall management of patients with malignant disease. Open discussions and case presentations form a key part of the programme. What does this oncology training include? Review of the manifestation, presentation, investigation and management of a range of common solid tumour types – breast, lung, colorectal, gastrointestinal, melanoma, renal, Explanation of imaging techniques and radiotherapy treatment with visits to these departments, Examination of patient management by specialist clinicians working in these tumour areas, The context of cancer care including the epidemiology of cancer and factors affecting treatment choices and prescribers’ decision-making. Topics included in this oncology course: Introduction to oncology and the epidemiology of cancer, Overview of available therapies, current chemotherapy, immunotherapy and radiotherapy practice, Common solid tumour types breast, lung, colorectal, gastrointestinal, melanoma, renal, New therapeutic options in oncology including immunotherapies, Department visits: radiotherapy and chemotherapy suites, outpatient clinics and radiology department. Chairman Professor Chris Twelves, St James’s University Hospital, Leeds, UK Is this hospital based oncology course for me ? This Oncology hospital based programme is designed to meet the broad information and education requirements of a range of pharmaceutical and biotech personnel from R&D, medical affairs, regulatory, strategic marketing and many others from both science and business functions. Accommodation for Oncology Clinical Experience. Details of the venue will be supplied on registration. Accommodation costs are not included in the course fee. However, Healthcare has organised a special bed and breakfast rate at our preferred hotel for delegates who require overnight accommodation – details of how to book will be provided with the joining instructions for the course. We do encourage delegates to book at this hotel, as daily transport from here to the venue will be provided.
Eintrags-ID:
912030
32
Innovate Cancer 2017 — Cancer Research
27. Nov 2017 - 28. Nov 2017 • Brisbane, Australien
Zusammenfassung:
The 2017 Innovate Cancer Research Conferences are a hub that covers the core aspects of Pathophysiology including “Oncology and Cancer Therapy, Blood Cancer, Prostate Cancer, Thyroid Cancer, Breast Cancer, Cervical Cancer, Pancreatic Cancer, Oral Cancer, Gynecologic Oncology, Brain Cancer, Organ specific cancers
Kontakt:
Tel.: [61-1-800-025-686];     Email:  Cancer@innovatecolloquiums.com
Eintrags-ID:
875584
33
Biomarkers Congress 2017 — Annual World Congress on Biomarkers & Clinical Research
27. Nov 2017 - 28. Nov 2017 • Atlanta, Vereinigte Staaten
Zusammenfassung:
PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in Biomarkers and its clinical researches. Listen to motivating keynotes from thought leaders, pioneers across the globe. Atlanta is all set for an amazing event as PULSUS proudly presents the “Annual World Congress on Biomarkers & Clinical Research” on November 27-28, 2017. PULSUS cordially welcome researchers, academicians, students and business professionals in the field of BIOMARKERS from around the world to participate in the upcoming BIOMARKERS CONGRESS 2017. The meeting for this year will revolve around the theme “Explore the latest Biomarkers development in health and clinical research” thus relaying the most cutting edge findings in the field of Biomarkers Research.
Kontakt:
Safina Robinson;     Tel.: [+1-800-982-0387];     Email: biomarkers@cmesocietyconferences.org
Themen:
Biomarker Conference, Biomarkers Conference 2017, Biomarkers Conferences, Biomarkers Congress, Biomarker Conferences USA, Biomarker Conferences, Biomarkers Congress 2017, Biomarker Conferences 2017, Biomarkers Society Conferences, Biomarkers cme conference
Eintrags-ID:
884380
34
Oncology Summit 2017 — International Oncology Summit
27. Nov 2017 - 28. Nov 2017 • Atlanta, Vereinigte Staaten
Zusammenfassung:
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. International Oncology Summit will have an anticipated participation of 120+ delegates across the world to discuss the conference goal
Kontakt:
Rayan Wayne;     Tel.: [8008582189];     Email: oncologyevents@alliedconferences.org
Themen:
Cancer Conferences USA, Cancer Meetings 2017, Oncology Conferences USA, Oncology Symposiums 2017, Oncology Conferences Atlanta.
Eintrags-ID:
902411
Verwandte Fachgebiete:
35
1st joint EACR-MRS Conference on Seed and Soil: In Vivo Models of Metastasis
27. Nov 2017 - 29. Nov 2017 • Berlin, Deutschland
Zusammenfassung:
We are pleased to invite you to join us at the 1st joint EACR-MRS Conference on Seed and Soil: In Vivo Models of Metastasis. Metastasis is responsible for over 90% of cancer patient deaths, largely due to the fact that therapies are generally ineffective against detectable metastatic tumours. This conference aims to address the crucial need to better understand the metastatic process in order to identify effective therapeutic strategies.
Kontakt:
Laura Strachan;     Email: l.strachan@nottingham.ac.uk
Themen:
metastasis, in-vivo, models, imaging, transgenic, modelling, MRS, therapeutic, strategies, tools, world-leading, latest, cancer, research
Eintrags-ID:
898670
36
Fortbildungsveranstaltung "Leitlinien-Update Onkologie": S3-Leitlinie Supportivtherapie
29. Nov 2017 • Berlin, Deutschland
Kontakt:
Juliane Truskowski;     Tel.: [03643 2468-129];     Email: juliane.truskowski@ng-akademie.de
Themen:
Onkologie, Supportivtherapie
Eintrags-ID:
936349
37
Oncology Trials: Focus on Phase III
29. Nov 2017 - 30. Nov 2017 • London, Großbritannien
Zusammenfassung:
What is Oncology: Phase III Trials? Oncology: Phase III Trials is a two-day, rapid and progressive training programme.  Led by specialist physicians face-to-face learning equips delegates with the knowledge required to discuss Oncology Trials confidently and credibly. Oncology: Phase III Trials is a high calibre, two-day training programme presented in London, UK. This interactive and informative course provides a comprehensive overview of the planning and implementation of oncology clinical trials, focusing on Phase III. The course will demonstrate how oncology trials differ in design and conduct from those in other therapy areas. Delegates learn to design trials to minimise the deficiencies that lead to inappropriate interpretation whilst maximising the competitive advantage. Delegates will hear the perspective of currently practicing oncologists with extensive experience of industry clinical trials as well as professionals who will discuss oncology clinical trial statistics and oncology product market entry. What will I learn about oncology clinical trials? You have the opportunity to learn from experts: How oncology trials differ in design and conduct from those in other therapy areas, How to design trials to minimise the deficiencies that lead to inappropriate interpretation whilst maximising the competitive advantage, Practicing oncologists with extensive experience of industry clinical trials & professionals discuss oncology clinical trial statistics and oncology product market entry. Topics include: Introduction to oncology clinical trial design and planning, Informed consent/patient information, The impact of trials on clinical practice, Statistical analysis and reporting, Health economics assessment, Quality of life assessment. Faculty includes: Professor Allan Hackshaw, Deputy Director, Cancer Research UK & UCL Cancer Trials Centre, Cancer Institute, University College London, London, UK Mr Jim Furniss, SVP, Global Market Access, GfK Market Access, UK Professor Chris Twelves, Professor of Clinical Pharmacology and Oncology, St James’s Institute of Oncology, UK Is this oncology clinical trials course for me? Oncology: Phase III Trials is ideal for pharmaceutical, medical technology and biotechnology industry personnel working in the area of oncology. It is appropriate for those involved in clinical research, medical affairs and regulatory functions, as well as individuals in strategic marketing and business functions.
Eintrags-ID:
912176
Verwandte Fachgebiete:
38
WCC-2017 — World Cancer Conference
29. Nov 2017 - 30. Nov 2017 • Florida, Vereinigte Staaten
Kontakt:
Carol Smith;     Tel.: [8005204889];     Email: carolsmith.oap@gmail.com
Themen:
Breast Cancer  Colorectal Cancer Lymphoma  Lung Cancer  Blood Cancer Gynecologic cancer  Cancer Treatment and Prevention Herbal Treatments for Cancer Stem Cell Transplants Cancer Diagnosis Cancer Biomarkers Metastatic Cancer  Cancer Genomics Skin cancer
Eintrags-ID:
898616
39
Miami Brain Symposium, Inaugural
01. Dez 2017 • Coral Gables, Vereinigte Staaten
Zusammenfassung:
Continuing medical education focused on the latest advances in neuro oncology. Dynamic faculty! Excellent and timely topics from experts in neuro oncology.
Kontakt:
Julie Zimmett;     Tel.: [786-596-2398];     Email: juliez@baptisthealth.net
Themen:
Brain cancer; neuro oncology
Eintrags-ID:
941497
40
Miami Neuro Symposium, Sixth Annual
02. Dez 2017 • Coral Gables, Vereinigte Staaten
Zusammenfassung:
Attendees will hear about the latest advances in neuro oncology, stroke treatment and neurocritical care from experts in the field.
Kontakt:
Julie Zimmett;     Tel.: [786-596-2398];     Email: juliez@baptisthealth.net
Themen:
Stroke treatment; Neurocritical care; Neuro Oncology; CME
Eintrags-ID:
941430
Verwandte Fachgebiete:
41
Global Cancer Meet and Expo
04. Dez 2017 - 06. Dez 2017 • Dubai, Vereinigte Arabische Emirate
Zusammenfassung:
Linkin Science, welcomes you all to the Global Cancer Meet and Expo, with the theme “Advanced insights in Cancer Therapeutics” which will be hosted in Dubai during December 04th - 06th, 2017.
Kontakt:
Daniel Becker;     Tel.: [+1 (415) 463-8448 ];     Email: cancermeet@linkinscience.com
Themen:
Cancer therapeutics, Cancer Diagnostics, Cancer Immunology, Clinical Research in Cancer, Metastatic carcinoma, OncoGenomics, Cell Biology and Cancer, Cancer stem cells and drug resistance, Breast cancer, Prostate Cancer, Lung Cancer, Other major cancer types, Cancer Prognosis, Cancer prevention and Management
Eintrags-ID:
900954
42
Training — Nurse Prescribing in Cancer Care
15. Dez 2017 • London, Großbritannien
Zusammenfassung:
This conference focuses on Nurse Prescribing in Cancer Care. Through national updates and practical case studies the conference will demonstrate how the effective use of nurse prescribing in cancer care can improve patient care, experience and outcomes. The conference will focus on developing competence and confidence in nurse prescribing in cancer care, including using the new National Competency Framework for all Prescribers. Follow the conference on Twitter #NMPCancer A 20% discount is available by quoting ref: hcuk20c-s when booking.
Kontakt:
8 Wilson Drive, Ottershaw, Surrey KT16 0NT;     Tel.: 0044/1932 429933;     Email: kerry@hc-uk.org.uk
Themen:
Nurse Prescribing, Cancer, Oncology
Eintrags-ID:
951145
43
Training — Non Medical Prescribing in Cancer Care
15. Dez 2017 • London, Großbritannien
Zusammenfassung:
This conference focuses on Non Medical Prescribing in Cancer Care. Through national updates and practical case studies the conference will demonstrate how the effective use of non medical prescribing in cancer care can improve patient care, experience and outcomes. The conference will focus on developing competence and confidence in non medical prescribing in cancer care, including using the new National Competency Framework for all Prescribers. Follow the conference on Twitter #NMPCancer A 20% discount is available by quoting ref: hcuk20c-s when booking.
Kontakt:
8 Wilson Drive, Ottershaw, Surrey KT16 0NT;     Tel.: 0044/1932 429933;     Email: kerry@hc-uk.org.uk
Themen:
Non Medical Prescribing, Cancer, Oncology, Pharmacy, Medicine Management
Eintrags-ID:
951144
44
Cancer Genetics Course 2018
29. Dez 2017 - 01. Feb 2018 • London, Großbritannien
Zusammenfassung:
The field of cancer genomics and recent technological advances are shaping how we diagnose and treat cancer. This skills based course will teach the core concepts of risk stratification using family history as a tool to enable patients to access appropriate management strategies. It is a course designed for all healthcare professionals working in primary care and specialist settings including oncology, breast care, gynae-oncology, gastroenterology and screening services. Participants will be equipped with the basics of cancer genetic counselling and sessions will include approaches to genetic testing, management of hereditary cancers and consent taking.
Eintrags-ID:
952381
Verwandte Fachgebiete:
45
Keystone Symposia: T Cell Dysfunction, Cancer and Infection
16. Jan 2018 - 20. Jan 2018 • Breckenridge, Vereinigte Staaten
Zusammenfassung:
T cell exhaustion is an acquired state of T cell dysfunction, associated with reduced T cell function, sustained expression of inhibitory receptors and a transcriptional state that is distinct from memory and effector T cells. T cell exhaustion is now recognized as a defining feature not only of chronic infections such as HIV, malaria and tuberculosis, but also of cancer. As a result, the search for effective approaches to reverse T cell exhaustion is the focus of immense therapeutic development. However, the similarities and differences between T cell dysfunction arising in chronic infection and tumors are not fully understood. Moreover, opportunities to identify new therapeutic approaches to reverse dysfunction based on parallels between the two disease states remain to be explored. This meeting will focus on the comparative biology and clinical therapeutics of T cell dysfunction in chronic viral infection and cancer. Drawing on leaders in fundamental T cell biology, computational science and clinical investigation, it will focus on common features and distinctive aspects of T cell dysfunction in cancer and chronic infection. The meeting will have broad relevance for T cell biology, tumor immunity, infectious disease and therapeutic development.
Kontakt:
Attendee Services; 970.262.1230; email: info@keystonesymposia.org
Eintrags-ID:
920841
Verwandte Fachgebiete:
46
Keystone Symposia: Tumor Metabolism
21. Jan 2018 - 25. Jan 2018 • Snowbird, Utah, Vereinigte Staaten
Zusammenfassung:
This conference brings together experts in the tumor metabolism field to discuss new concepts in the regulation and role of cancer metabolism in tumor growth, as well as strategies for targeting tumor metabolism for therapeutic benefit. This symposium is the premier conference for learning about the most important unpublished data in the tumor metabolism field and is invaluable to enhance accelerated discovery and development of new therapeutic approaches to target cancer metabolism.
Kontakt:
Attendee Services;     Tel.: [970.262.2677 or 800.253.0685];     Email: info@keystonesymposia.org
Themen:
cancer research, basic mechanism, mitochondria, epigenetics
Eintrags-ID:
926108
47
2nd International Symposium on Tumor-Host Interaction in Head and Neck Cancer and 3rd International Symposium on HPV Infection in Head and Neck Cancer
25. Jan 2018 - 27. Jan 2018 • Essen, Deutschland
Zusammenfassung:
This time it will be a joint meeting together with the 3rd International Symposium on HPV Infection in Head and Neck Cancer thus taking onto account the fact that infections with cancer-causing human papillomaviruses (HPV) are becoming more and more common among patients. Additionally, our congress continues as well the series of annual meetings on experimental head and neck oncology in collaboration with the Working Group Oncology of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery.
Eintrags-ID:
937562
Verwandte Fachgebiete:
48
Pathology Update 2018: What you need to know about new AJCC staging and WHO classifications
25. Jan 2018 - 27. Jan 2018 • Phoenix, Vereinigte Staaten
Zusammenfassung:
Dr. Mahul Amin, editor of the 8th edition of the AJCC Cancer Staging Manual, joins an elite roster of speakers for this third annual 2.5-day general surgical pathology course.  Covering a broad range of subjects in diagnostic pathology, the central themes for this year's course include staging changes found in the 8th edition of the AJCC tumor staging manual, and updates in WHO classification.  Organ systems discussed include breast, head and neck, gastrointestinal, pulmonary, soft tissue, gynecologic, genitourinary, endocrine, and hematologic.  Presentations will summarize changes to terminology and staging; these lectures also include practical discussion of diagnostic challenges, need-to-know molecular updates, and emerging issues.  Attendee participation is encouraged via audience response system and engaging case reviews.
Eintrags-ID:
941981
49
CAM2018 — Clinical Advances in Myeloma 2018
31. Jan 2018 • London, Großbritannien
Zusammenfassung:
The clinical advances in multiple myeloma have made great strides over the past few years, with the advent of novel therapeutic drugs dramatically improving both remission and survival rates in myeloma patients. There is still however a great deal of research currently underway investigating both current and emerging treatments in order to develop the most effective clinical practices in the treatment of multiple myeloma. Myeloma 2018 is a one day CPD certified conference, in association with The British Journal of Hospital Medicine, that aims to provide healthcare professionals with the most up-to-date clinical knowledge regarding the diagnosis, treatment and management of myeloma. This conference also provides the unique opportunity for clinicians to discuss the current controversial topics in myeloma in interactive case studies and panel discussions led by experts in the field.
Kontakt:
Jack Tituana;     Tel.: [02075016761];     Email: jack.tituana@markallengroup.com
Themen:
Immunotherapy, stem-cell, patient centred models of care, treatments, myeloma. smouldering myeloma, imaging, radiology, diagnostic
Eintrags-ID:
954628
Verwandte Fachgebiete:
50
PRIMO — Practical Recommendations in Immuno and Molecular Oncology (PRIMO) Meeting
31. Jan 2018 - 03. Feb 2018 • Maui, Vereinigte Staaten
Zusammenfassung:
The PRIMO Meeting is an annual 3-day single-track conference focusing on the practical applications of emerging immuno and molecular oncology. Each day’s agenda is dedicated to specific tumor types, with the top experts sharing the latest data and applying them to real world cases.
Kontakt:
Jennifer Mahon;     Tel.: [1-855-6-PRIMO-8 (1-855-677-4668)];     Email: support@primomeeting.org
Themen:
oncology, immunology, continuing medical education
Eintrags-ID:
907331
51
4th EACR conference on A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Cancer Treatments
01. Feb 2018 - 03. Feb 2018 • Amsterdam, Niederlande
Zusammenfassung:
Evading cell death is a hallmark of cancer cells, which contributes to tumour growth and therapeutic resistance. But cancer cells also highjack mechanisms like protective autophagy or senescence to promote tumour growth. Cell death is an important determinant of the immune response to cancer, which may either increase the antitumour effect or promote tumour growth. The conference will cover exciting new insights into this highly-relevant field, so please join us in Amsterdam to be stimulated by the latest research updates! With its translational character, the conference has been designed for basic and translational cancer scientists, as well as oncologists who are interested in the multifaceted role of cell death in cancer.
Kontakt:
Roger Doxat-Pratt;     Email: roger.doxat-pratt@nottingham.ac.uk
Themen:
cell-death, tumour, tumor, growth, therapeutic, resistance, autophagy, senescence, immune, mechanisms, basic, apoptotic, therapies, world-leading, latest, cancer, research
Eintrags-ID:
934073
Verwandte Fachgebiete:
52
Updates in Cardio-Oncology 2018: Challenges and New Frontiers
01. Feb 2018 - 03. Feb 2018 • Scottsdale, Vereinigte Staaten
Zusammenfassung:
This course reviews clinically important information regarding the management of cardiac and vascular diseases affecting patients with cancer and cancer survivors. The interactive, practice-based format includes case presentations and state-of-the-art lectures in recent and topical developments in this emerging field. The goal is to improve quality, safety and outcomes for patients within the dynamic and interactive educational experience. The current state of knowledge of common cardiovascular complications such as heart failure (HF), myocardial ischemia, hypertension (HTN), thromboembolism, QT prolongation, and bradycardia is associated with frequently used anticancer medications.  An optional hands-on echocardiography workshop will be available.  Pre-registration is required.
Eintrags-ID:
957126
Verwandte Fachgebiete:
53
IOS — Indo Oncology Summit
02. Feb 2018 - 04. Feb 2018 • Bhubaneswar, Indien
Zusammenfassung:
It is a great pleasure for us to invite you to be a part of the Indo Oncology Summit to be held at Bhubaneswar, India between 2nd – 4th February, 2018. The theme of the conference is “Incubating Innovations, Redefining Cancer”. This will be unique forum for clinicians and scientists to review and discuss advances in early detection, prevention, treatment and rehabilitation of oral cancer. The program is carried out in partnership with more than 15 national and international organizations of various countries.

IOS is a multi-disciplinary international organization that brings together clinicians and scientists, working on issues relating to the etiopathogenesis, epidemiology, prevention and management of cancer.

Kontakt:
Dr. Sunil Rout;     Tel.: [7358737843];     Email: research@indooncologysummit.com
Themen:
cancer, oncology
Eintrags-ID:
943576
54
Keystone Symposia - Cancer Epigenetics: New Mechanisms, New Therapies
10. Feb 2018 - 14. Feb 2018 • Breckenridge, Colorado, Vereinigte Staaten
Zusammenfassung:
The field of epigenetics has recently emerged as an essential component of oncology research, with altered epigenetic modifications considered to be critical hallmarks of cancers. Unlike mutations, epigenetic aberrations are reversible and as a result, epigenetic therapies hold great promise as anti-cancer agents. For these novel therapies to succeed, a key challenge is to fully understand the nature and the mechanisms that lead to epigenetic changes in cancer. Another essential challenge is to make sense of the avalanche of data flowing from increasingly powerful "omics-based" technologies. Despite these challenges, never has the potential for scientific and clinical breakthroughs in this field been greater. Bringing together both the academic and the pharmaceutical communities, this Keystone Symposia conference will focus on: 1) The newest findings concerning the mechanisms by which epigenetic pathways are established and maintained in normal and stem cells, and how these go awry during aging and cancer, with a special emphasis on histone modifications, chromatin remodeling and the unexpected increased number of DNA modifications ((hydroxy)methylcytosine and methyladenine); 2) The growing roles of noncoding RNAs in cancer and the emergence of the new and exciting realm of RNA epigenetics; 3) Use of new omics technologies to interrogate altered epigenetic landscapes in tumors and assess their clinical implications; and 4) Novel and promising therapeutic drugs aimed at reversing specific epigenetic alterations. Ultimately, the meeting will provide great opportunities for senior and junior scientists to meet the leaders in the field from both academia and industry, hence forging exciting interdisciplinary interactions and creating potential new collaborations in the booming area of cancer epigenetics.
Kontakt:
Attendee Services;     Tel.: [970.262.1230];     Email: info@keystonesymposia.org
Themen:
Cancer, genetics, genomics, drug discovery, epigenetics
Eintrags-ID:
948488
55
Focal 2017 — 10th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer
11. Feb 2018 - 13. Feb 2018 • Noordwijk, Niederlande
Zusammenfassung:
The “10th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer” will be he held in Noordwijk - Amsterdam, The Netherlands, on February 11th -13th, 2018. The Symposium was initiated in 2008 and ever since it has been rotating between the USA and Amsterdam. This year’s Symposium is organized by Prof. Jean De la Rosette and his team at the AMC University Hospital in Amsterdam in collaboration with the Department of Urology of Duke University in Durham, NC and the USC Institute of Urology in Los Angeles, CA in the USA.
Kontakt:
Email: focal@focaltherapy.org
Eintrags-ID:
873644
Verwandte Fachgebiete:
56
DDRC — 3rd DNA Replication/Repair Structures and Cancer - Fusion Conferences
11. Feb 2018 - 15. Feb 2018 • Cancun, Mexiko
Zusammenfassung:
Join scientific chairs Prof. Tom Blundell (University of Cambridge) and Prof. John Tainer (LBL & MD Anderson Cancer Center) in Cancun for the third conference in this series, described by Prof. Ben Van Houten from University of Pittsburgh: ‘I can honestly say your meeting, by combining hard core structure-function studies with beautiful biology, hits an important area that many meetings miss; being part of that science is just terrific.’
Kontakt:
Laura Trundle;     Tel.: [01638 724137];     Email: laura@fusion-conferences.com
Themen:
DNA replication, DNA repair, DNA damage, cancer, replication complexes, mutational signatures, kataegis, synthetic lethality, chromatin, chromosome instability, epigenetics, PARP, PARG, metabolic signaling, mitochondrial replication, mitochondrial repair, RNA damage responses, apoptosis
Eintrags-ID:
884630
Verwandte Fachgebiete:
57
3rd DNA Replication/Repair Structures and Cancer - Fusion Conferences
11. Feb 2018 - 15. Feb 2018 • Cancun, Mexiko
Zusammenfassung:
The remarkable stability of the human genome is lost in cancer cells due to the failure of efficient and accurate repair in the context of oncogene-induced replication stress and elevated transcription. DNA replication is furthermore emerging as a surprisingly fragile and complex process requiring fork protection and restart, template-switching, R-loop resolution, gap-filling, and repair. Unresolved replication and repair intermediates signal apoptosis. The synthetic lethality and essentiality resulting from replication-repair stresses thus suggest repair inhibitors as tools to control pathway selection and damage outcomes and to design advanced therapeutics. The 3rd DNA Replication/Repair Structures & Cancer conference in February 2018 will focus on structural and mechanistic insights into dynamic protein, chromatin, DNA and RNA complexes acting in DNA replication and repair events relevant to cancer. Conference talks and discussions will center on developing an actionable mechanistic knowledge of DNA replication and repair stress responses suitable to guide advanced intervention strategies for cancer. The conference will emphasize an environment suitable for initiating productive collaborations. It will include vibrant informal and formal discussions together with informative talks and poster sessions. To include late-breaking advances and innovating new investigators, one or more talks for every session will be selected from submitted abstracts. Meeting attendance is limited.
Eintrags-ID:
912294
Verwandte Fachgebiete:
58
Keystone Symposia - Phosphoinositide Biology: New Therapeutic Targets Beyond Class I PI3K
11. Feb 2018 - 15. Feb 2018 • Taos, New Mexico, Vereinigte Staaten
Zusammenfassung:
Phosphoinositides have been recognized since the 1980s as important regulatory lipids supporting signal transduction from G protein-coupled receptors and receptor tyrosine kinases. The discovery of PI 3-kinases and their roles in carcinogenesis and immune regulation has created a fertile ground for translational expansion of the phosphoinositide field with a focus on cancer and inflammation. Most of these advances focused on Class I PI3Ks and PIP3-mediated signaling. However, research on other PI kinases and phosphoinositides has expanded substantially over the years. Class II and -III PI 3-kinases and less characterized 3-phosphorylated phosphoinositides are now rapidly emerging as key controllers of development, trafficking, nutrition-sensing and autophagy. Furthermore, phosphoinositides different from the 3-phosphorylated species are gaining momentum in many aspects of cell physiology and pathology. Exciting new developments include PI 4-kinases controlling vesicular trafficking and non-vesicular lipid transfer between membrane contacts, and new details are emerging on the role of inositol lipid phosphatases in trafficking, endocytosis and ciliary function. The recently recognized roles of PI 4-kinases as obligate host factors for certain RNA viruses, and their importance in parasitic organisms such as Plasmodium falciparum or Legionella pneumophila, have raised significant interest from pharmaceutical companies that now focus on inositol lipids other than the products of PI 3-kinases. By expanding our knowledge of phosphoinositides beyond class I PI3K products, this Keystone Symposia meeting represents a unique opportunity to bolster the rising interest in these under-explored avenues with a strong potential for translational impact.
Kontakt:
Attendee Services;     Tel.: [970.262.1230];     Email: info@keystonesymposia.org
Themen:
development, drug discovery, cancer, infectious disease, cell signaling, genetics, cell physiology
Eintrags-ID:
948420
59
Keystone Symposia - Emerging Cellular Therapies: T Cells and Beyond
11. Feb 2018 - 15. Feb 2018 • Keystone, Colorado, Vereinigte Staaten
Zusammenfassung:
A new community of researchers is emerging that focuses on studying and developing cellular therapies against cancer and chronic infections. The field is advancing rapidly due to our deepening understanding of cell biology. New technologies permit efficient cell culture, gene transfer and genetic editing, enabling autologous and allogeneic cell therapy. With rapid development of CAR T cells, breakthrough FDA approval status, and fast-tracking clinical trials, competition is fierce in the biotechnology and pharmaceutical industries. Cell therapies with stem cells and T cells are in advanced clinical development that will enable widespread use for cancer and chronic infections such as HIV. Infusions of regulatory T cells (Tregs) have the potential to benefit patients with autoimmunity and transplantation. A goal of this conference is to bring together basic and translational scientists from these fields to identify current opportunities and challenges in cell therapies. Another goal is to bridge the fields of effector T cell and Treg cell therapies. The interdisciplinary features of this meeting should facilitate new collaborations and interactions between investigators who would not normally meet. This meeting is paired with the Keystone Symposia conference on "Lymphocytes and their Roles in Cancer."
Kontakt:
Attendee Services;     Tel.: [970.262.1230];     Email: info@keystonesymposia.org
Themen:
T cell and B cell biology, cancer, genetics, genomics, drug discovery, infectious disease, HIV, translational medicine, stem cells
Eintrags-ID:
948496
Verwandte Fachgebiete:
60
Keystone Symposia: Lymphocytes and their Roles in Cancer
11. Feb 2018 - 15. Feb 2018 • Keystone, Colorado, Vereinigte Staaten
Zusammenfassung:
Leverage of the body’s own immune system is revolutionizing the way that we treat cancer as it can lead to dramatic and durable responses. Such anti-tumor therapies include reactivation of anti-tumor T cells, expansion of tumor-infiltrating lymphocytes (TILs), Chimeric antigen receptor (CAR) T cells and a variety of cancer vaccines. The focus or target of most these approaches are cells of the lymphocytic lineage (T, B, NK, dendritic cells), key components of both adaptive and innate immune response. At the same time, lymphocytes can also be malignant, as in the case of a large number of lymphocytic leukemia and lymphoma subtypes, and active components of the immune microenvironment, controlling tumor growth and anti-tumor response. This conference for the first time brings together scientists from these different areas of lymphocyte biology and provides an overview of lymphocyte development, transformation, terminal differentiation, location within the tumor microenvironment and anti-tumor activity. The conference also provides an update on novel therapy protocols that attempt to harness the function of lymphocytes against cancer and state-of-the-art technologies, including imaging and DNA/RNA sequencing approaches, that will help us visualize and molecularly dissect anti-tumor responses in experimental systems and cancer patients.
Kontakt:
Attendee Services;     Tel.: [970.262.1230];     Email: info@keystonesymposia.org
Themen:
cancer, immunology, drug discovery, technologies, T cell biology, genetics, genomics
Eintrags-ID:
948482
61
Biomarkers Congress — 13th Annual Biomarkers Congress
15. Feb 2018 - 16. Feb 2018 • Manchester, Großbritannien
Zusammenfassung:
Over 55 presentations, case studies, novel technologies, round-table and panel discussions focused on the opportunities and challenges of biomarker research discovery and development in a variety of therapeutic areas such as immune-oncology, neuroscience and cardio vascular disease areas, precision medicine, companion diagnostics, data integration methods, and utilising biomarkers in clinical trials
Kontakt:
Oxford Global Oxford Global;     Tel.: [1865248455];     Email: d.dalby@oxfordglobal.co.uk
Themen:
biomarker research discovery and development, immune-oncology, neuroscience, cardio vascular disease, precision medicine, companion diagnostics, data integration methods, biomarkers in clinical trials
Eintrags-ID:
928586
62
Clinical and Multidisciplinary Hematology & Oncology: The 15th Annual Review
16. Feb 2018 - 18. Feb 2018 • Scottsdale, Vereinigte Staaten
Zusammenfassung:
This course will include a comprehensive update and management strategies of issues in hematologic and oncologic malignancies presenting new disease classification, treatment, and challenging cases. Course topics will focus on key hematologic diseases (dysproteinemias, acute and chronic leukemias, lymphomas), key solid tumors (breast, thoracic, GI, GU), and overlap topics of supportive, ancillary and diagnostic care. The course offers challenging and interactive sessions on pertinent issues involved with the care of patients.
Eintrags-ID:
920921
Verwandte Fachgebiete:
63
The 2nd International Congress on Clinical Trials in Oncology and Hemato-Oncology
19. Feb 2018 - 20. Feb 2018 • Berlin, Deutschland
Eintrags-ID:
920953
Verwandte Fachgebiete:
64
DKK2018 — 33. Deutscher Krebskongress 2018
21. Feb 2018 - 24. Feb 2018 • Berlin, Deutschland
Zusammenfassung:
Der DKK führt über 10.000 onkologisch tätige Experten zusammen und fördert somit die interdisziplinäre Zusammenarbeit zwischen den einzelnen Fachdisziplinen. In rund 400 Sitzungen verschiedener Formate ermöglicht er an vier Tagen kompakt und intensiv eine Bestandsaufnahme der aktuellen Forschungsergebnisse und der Situation in der Onkologie in Deutschland. Behandelt werden neben aktuellen und künftigen medizinischen Entwicklungen und neuen Therapien für alle Tumorentitäten auch gesundheitspolitische Fragen – das Kongressprogramm umfasst traditionell einen Programmstrang zur Gesundheitspolitik.
Themen:
Diagnose, Therapie, (Über-)Leben, Radiologie, Nuklearmedizin, Pathologie, Tumortherapie, Lungenkarzinom, Oligometastasierung, Prostatakarzinom, Neuroonkologie, Palliativmedizin, Pankreaskarzinom, Sarkomen, Mammakarzinom, Leukämien und Lymphomen, Melanom, Rektumkarzinom, Immuntherapie, Psychoonkologie und Kopf-Hals-Tumoren
Eintrags-ID:
925855
65
Fusion Conferences — Nuclear Receptors (New Roles for Nuclear Receptors in Development, Health and Disease) - Fusion conference
27. Feb 2018 - 02. Mär 2018 • Cancun, Mexiko
Zusammenfassung:
Join scientific chairs Charlotte Bevan (Professor of Cancer Biology, Imperial College London), Karen Knudsen (Sidney Kimmel Cancer Center, TJU, Thomas Jefferson University) and Simak Ali (Principal Investigator, Imperial College London) at the Nuclear Receptors (New Roles for Nuclear Receptors in Development, Health and Disease) Fusion conference in Mexico.
Kontakt:
Sarah Trundle;     Tel.: [01638 724137];     Email: sarah@fusion-conferences.com
Themen:
nuclear receptors, physiologically, pharmacologically, ageing, aging, DNA damage repair pathways, therapeutic target, steroid signalling, estrogen receptor, antiestrogens, androgen, aromatase inhibitors, transcriptional processes, drug development, health, disease, cancer, glucocorticoid receptor, nuclear receptor, crosstalk, epigenetic control, epigenetic regulation, circadian rhythms, cellular pathways, breast cancer, NR-targeting, prostate cancer, small molecules, non coding RNA, DNA damage, cell cycle, metabolism, metabolic disease, CNS, Endocrinology, Oncology, Paediatrics, Urology, Gynaecology, Obstetric Medicine, Neuroscience, Cardiology.
Eintrags-ID:
897820
Verwandte Fachgebiete:
66
TAT 2018 – Targeted Anticancer Therapies
05. Mär 2018 - 07. Mär 2018 • Paris, Frankreich
Zusammenfassung:
In a constantly evolving oncology environment, ESMO continues to expand its educational offer and conference portfolio and is pleased to announce that as of 2018 ESMO is taking on the TAT Congress, which will now be held on an annual basis in Europe. The goals and the design of phase 1 studies have changed from just safety/toxicity to now include clinical activity/response and biomarker research. This new phase 1 paradigm has already led to rapid, conditional, approval of several new cancer therapeutics showing outstanding clinical activity in early-phase studies. TAT focuses on early-phase development and translational research. The programme will cover targeted agents, immuno-oncology and combinations involving such agents. We hope to see you at TAT 2018!
Eintrags-ID:
956668
67
28th Annual Interdisciplinary Breast Center Conference
09. Mär 2018 - 14. Mär 2018 • Las Vegas, Vereinigte Staaten
Zusammenfassung:
The 28th Annual Interdisciplinary Breast Center Conference has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through a joint sponsorship of the University of Tennessee College of Medicine, an educational institution accredited by the ACCME to provide continuing medical education for physicians, and the National Consortium of Breast Centers, an international member-based organization of medical and industry professionals.
Kontakt:
Kimberly Bolin;     Tel.: [(574)401-8115];     Email: kimberly@breastcare.org
Themen:
RT/Imaging, Breast Surgical Oncology, Breast Radiation Oncology
Eintrags-ID:
937410
68
2nd EACR conference on Radiation Break-through: from DNA damage responses to precision cancer therapy
12. Mär 2018 - 14. Mär 2018 • Oxford, Großbritannien
Zusammenfassung:
This is the second EACR conference focused on this topic. It is designed to be of interest to cancer scientists and medical oncologists with expertise in basic, translational and clinical research. Its objective is to cover recent and exciting developments in the field that are crucial to our understanding of the multifaceted role of the DNA damage response and associated tumour cell specific alterations in cancer initiation, progression and precision cancer therapy. It is an exciting and rapidly evolving research field that will expedite the development and implementation of biomarkers for patient stratification and of novel treatment concepts in precision cancer medicine.
Kontakt:
Laura Strachan;     Email: l.strachan@nottingham.ac.uk
Themen:
radiation, breakthroughs, DNA, damage, responses, precision, therapy, therapies, genome, radiotherapy, chemotherapy, tumour, tumor, radiobiology, biomarkers, world-leading, latest, cancer, research
Eintrags-ID:
934221
Verwandte Fachgebiete:
69
48. Kongress der Deutschen Gesellschaft für Endoskopie und Bildgebende Verfahren e.V.
15. Mär 2018 - 18. Mär 2018 • München, Deutschland
Kontakt:
Martina Wiederkrantz;     Tel.: [089 8906770];     Email: martina.wiederkrantz@cocs.de
Eintrags-ID:
903315
Verwandte Fachgebiete:
70
ITOC5 — 5th Immunotherapy of Cancer Conference
19. Mär 2018 - 21. Mär 2018 • Berlin, Deutschland
Zusammenfassung:
The ITOC series of conferences is the premier meeting for education, scientific exchange and networking within cancer immunotherapy. The fifthedition (ITOC5) will take place in Berlin, Germany, from 19 to 21 March 2018. It aims at providing a forum for all professionals working in immunotherapy to discuss early clinical drug development and address the unique challenges of translational research. The programme will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring and biomarker development. At this conference, we are in particular addressing preclinical and clinical scientists, clinical investigators, postdoctoral fellows involved in cancer research, regulatory scientists, healthcare professionals and the pharmaceutical industry.
Eintrags-ID:
956698
71
Gordon Research Seminar — DNA Damage, Mutation and Cancer
24. Mär 2018 - 25. Mär 2018 • Ventura, CA, Vereinigte Staaten
Zusammenfassung:
The Gordon Research Seminar on DNA Damage, Mutation and Cancer is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.
Eintrags-ID:
953650
Verwandte Fachgebiete:
72
Gordon Research Conference — DNA Damage, Mutation and Cancer
25. Mär 2018 - 30. Mär 2018 • Ventura, CA, Vereinigte Staaten
Zusammenfassung:
The 2018 Gordon Research Conference on DNA Damage, Mutation and Cancer is developed around the theme of exploiting fundamental knowledge to advance treatment and prevention. Rich and ever-increasing information is available on the specific mutations that are the molecular basis of cancer. Many mutations can be traced to specific types of damage to the DNA, while others arise from DNA replication errors or unknown causes. Technologies are being refined to determine the origins of these mutations, and monitor the accuracy and reproducibility of cancer genomic data. Biological and structural analyses can assess which mutations are functionally relevant. Specific mutations can confer vulnerabilities, making individual cancers more responsive to treatment with DNA damaging agents.
Eintrags-ID:
953695
Verwandte Fachgebiete:
73
Cancer Imaging and Therapy
02. Apr 2018 - 06. Apr 2018 • Hollywood, Vereinigte Staaten
Zusammenfassung:
The Cancer Imaging and Therapy conference will focus on optical methods in cancer, centered on imaging and treatment of cancer. The conference will accept submissions on topics on the molecular and cellular level, such as reporters and theranostics; on the tissue and pre-clinical (animal) level, such as pathology methods and advances in imaging of tumor models; and on human tissue and living human subjects, when specifically dealing with cancer. More generic biomedical optics and biophotonics research involving human tissues or living human subjects should be submitted to the Clinical and Translational Biophotonics conference at this congress.
Eintrags-ID:
836384
74
EMBO Workshop — Perspectives on skin cancer prevention
08. Apr 2018 - 11. Apr 2018 • Les Diablerets, Schweiz
Themen:
Molecular Medicine | Cell & Tissue Architecture
Eintrags-ID:
916382
Verwandte Fachgebiete:
75
ELCC 2018 — European Lung Cancer Congress
11. Apr 2018 - 14. Apr 2018 • Genf, Schweiz
Zusammenfassung:
ESMO and IASLC are pleased to announce that the 8th edition of the European Lung Cancer Congress (ELCC), will take place 11-14 April, in Geneva, Switzerland. The European Lung Cancer Congress is a collaborative effort of the most important multidisciplinary societies representing thoracic oncology specialists, all working towards a shared goal: to advance science, disseminate education and improve the practice of lung cancer specialists worldwide.  We invite you to save the date! Main themes: Immunotherapy: towards combinations, SCLC and mesothelioma, Implementation of lung cancer screening, First-line treatment of oncogene and non-oncogene addicted tumours    , Molecular background of lung cancer, Biomarkers of NSCLC.
Eintrags-ID:
956211
Verwandte Fachgebiete:
76
Acute Leukemia Forum 2018
12. Apr 2018 - 13. Apr 2018 • Newport Beach, Vereinigte Staaten
Zusammenfassung:
Since new discoveries and breakthroughs are critical to advance the treatment and management of acute leukemia, there is an urgent need to communicate the latest developments in the basic biology, induction and post-remission therapy, bone marrow transplant, and supportive care perspectives of ALL, AML, and MDS to physicians. The Acute Leukemia Forum (ALF) is a unique platform that enables worldwide prominent experts to share and discuss the latest research impacting treatment and management of these patients. ALF will focus on addressing the identified educational needs of healthcare professionals involved in caring for patients with acute leukemia and myelodysplasia.
Eintrags-ID:
956264
Verwandte Fachgebiete:
77
GEST 2018 — Global Embolization Symposium Technologies
17. Mai 2018 - 20. Mai 2018 • Miami Beach, FL, Vereinigte Staaten
Zusammenfassung:
Global Embolization Symposium and Technologies (GEST) serves as the definitive international embolotherapy resource, providing both clinically relevant research updates from the field and highly practical instruction. GEST 2018 U.S. will feature interactive education in the form of lectures, workshops, case presentations, oral abstract presentations and Q & A sessions. Exhibits showcasing the latest technology and services in support of the field also play a role in the important exchange of information. GEST 2018 will take place at the Lowes Miami Beach, an exquisite oceanfront backdrop within vibrant South Beach offering, in addition to learning, terrain to explore day and night.
Kontakt:
Tel.: [305-279-2263];     Email: questions@ccmcme.com
Eintrags-ID:
927212
78
6. Ludwigshafener GastroTage 2018 — 6. Ludwigshafener GastroTage 2018 - Endoskopie und CED im Dialog
08. Jun 2018 - 09. Jun 2018 • Ludwigshafen am Rhein, Deutschland
Kontakt:
Felicitas Molnar;     Tel.: [089/8906770];     Email: felicitas.molnar@cocs.de
Themen:
Live-Endoskopie, Live-Sonografie, Endosonografie
Eintrags-ID:
955890
Verwandte Fachgebiete:
79
Cancer and Metabolism 2018
25. Jun 2018 - 27. Jun 2018 • Cambridge, Großbritannien
Zusammenfassung:
This conference will cover the basic and latest aspects of the metabolic transformation in cancer and will highlight potential therapeutic approaches to target cancer-specific metabolic pathways.
Kontakt:
Email: events@abcam.com
Themen:
Introduction to metabolism and metabolic signaling in cancer, advanced technologies in cancer metabolism, targeting metabolism for cancer therapy
Eintrags-ID:
939995
80
ICHSHC 2018 — 17th International Congress on Hormonal Steroids and Hormones & Cancer
26. Nov 2018 - 29. Nov 2018 • Stellenbosch, Südafrika
Zusammenfassung:
The Department of Biochemistry at Stellenbosch University has a long history in steroid research and we are excited to welcome both our local and international colleagues to our institution located in the world-famous winelands of Stellenbosch. The conference coincides with the centenary of Stellenbosch University and forms part of our celebrations. In addition, the conference precedes the 18th International Congress of Endocrinology, which will be held at the Cape Town Convention Centre, Cape Town, South Africa, from 1-4 December 2018. The objective of this conference is to promote interaction and discussion within the field of steroid hormones and hormone-dependent cancers.
Kontakt:
Dawne Johnson;     Tel.: [+27 (0)21 938 9082];     Email: dawnej@sun.ac.za
Themen:
Steroidogenesis, disorders and diseases, Nuclear receptor signalling, Hormone dependent cancers
Eintrags-ID:
946552
Verwandte Fachgebiete:


Conference-Service.com stellt der Öffentlichkeit ein Kalendarium wichtiger Konferenzen, Symposien und sonstiger Tagungen im wissenschaftlich-technischen Bereich zur Verfügung. Obwohl das Verzeichnis mit großer Sorgfalt zusammengestellt und ständig aktualisiert wird, weisen wir auf die Möglichkeit von Fehlern ausdrücklich hin. Bitte vergewissern Sie sich immer beim Veranstalter, bevor Sie über die Teilnahme oder Nichtteilnahme an einer Konferenz entscheiden.

Organisatoren können kostenlos ihre Konferenzankündigungen veröffentlichen.

Stand vom 15. Oktober 2017